Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Bidirectional neuromuscular interface based on associative plasticity for stroke therapy during activities of daily living

Project description

Wearable device for stroke rehabilitation

Stroke is a leading cause of disability worldwide. The Neubond device offers wearable, autonomous therapy for stroke survivors by detecting muscle activity and delivering real-time stimulation to boost recovery. Using volition-induced paired associative stimulation (VIPAS), it promotes neuroplasticity without the need for complex setups. Early trials have shown improved motor function and reduced spasticity, supporting greater accessibility and patient compliance. The ERC-funded Neubond project will further develop the prototype, pursue regulatory approval, and conduct safety and usability testing. The aim is to support commercialisation and create spin-out companies. Neubond builds on insights from the ERC Synergy grant Natural BionicS, which focuses on bi-directional brain-muscle interfaces to restore movement.

Objective

Stroke is a leading cause of disability globally, with millions affected each year. A critical challenge in stroke recovery is the limited availability and intensity of rehabilitation therapies, which often fail to meet recommended guidelines. The neubond device, aims to address this by delivering autonomous, wearable therapy to stroke survivors during their daily activities. The device detects muscle activity through muscle signals and provides real-time stimulation to enhance motor recovery. By leveraging our novel volition induced paired associative stimulation (VIPAS) approach, the system stimulates neuroplasticity and facilitates muscle contractions, accelerating functional improvements without the need for complex setups or screen-based exercises. Initial trials have demonstrated significant improvements in motor function and usability, with a reduction in spasticity and increased range of motion. Our concept aligns with the unmet need for continuous, accessible rehabilitation, bridging the gap between clinical and home-based care. The device non-invasive, autonomous design enhances patient compliance, ensuring consistent therapy outside of scheduled sessions. The project leverages findings from the ERC Synergy grant Natural BionicS, focusing on bi-directional brain-muscle interfaces. The project aims to advance the prototype towards regulatory compliance, safety, and usability testing, ultimately driving commercialisation and spinout formation. Our device presents a high-gain potential, with significant cost savings for healthcare providers and enhanced quality of life for stroke survivors.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-POC

See all projects funded under this call

Host institution

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
Net EU contribution
€ 150 000,00
Address
SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
SW7 2AZ London
United Kingdom
Region
London Inner London — West Westminster
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)